Home
PHGE
PHGE News

Latest BiomX Inc. COmmon Stock (PHGE) News on December 23, 2024

BiomX Inc. Receives Notice of Compliance with NYSE American Continued Listing Standards

GlobeNewswire

7 days ago

BiomX Inc. Receives Notice of Compliance with NYSE American Continued Listing Standards

BiomX Announces Third Quarter 2024 Financial Results and Provides Business and Program Updates

GlobeNewswire

a month ago

BiomX Announces Third Quarter 2024 Financial Results and Provides Business and Program Updates

BiomX to Host Third Quarter 2024 Financial Results Conference Call and Webcast on November 14, 2024

GlobeNewswire

a month ago

BiomX to Host Third Quarter 2024 Financial Results Conference Call and Webcast on November 14, 2024

BiomX announces mandatory unit separation

TipRanks

2 months ago

BiomX announces mandatory unit separation

BiomX Announces a Mandatory Unit Separation

GlobeNewswire

2 months ago

BiomX Announces a Mandatory Unit Separation

BiomX to Provide Latest Update on Positive Phase 1b/2a Clinical Trial Data for BX004 at the North American Cystic Fibrosis Conference

GlobeNewswire

3 months ago

BiomX to Provide Latest Update on Positive Phase 1b/2a Clinical Trial Data for BX004 at the North American Cystic Fibrosis Conference

BiomX to Present at the H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire

4 months ago

BiomX to Present at the H.C. Wainwright 26th Annual Global Investment Conference

BiomX to Present Positive Phase 1b/2a Clinical Trial Data for BX004 at the European Respiratory Society (ERS) Congress 2024

GlobeNewswire

4 months ago

BiomX to Present Positive Phase 1b/2a Clinical Trial Data for BX004 at the European Respiratory Society (ERS) Congress 2024

UPDATE ON UNITS - BiomX Inc. Announces 1-for-10 Reverse Stock Split

GlobeNewswire

4 months ago

UPDATE ON UNITS - BiomX Inc. Announces 1-for-10 Reverse Stock Split

BiomX Inc. Announces 1-for-10 Reverse Stock Split

GlobeNewswire

4 months ago

BiomX Inc. Announces 1-for-10 Reverse Stock Split

BiomX Reports Second Quarter 2024 Financial Results and Provides Business and Program Updates

GlobeNewswire

4 months ago

BiomX Reports Second Quarter 2024 Financial Results and Provides Business and Program Updates

BiomX to Host Second Quarter 2024 Financial Results Conference Call and Webcast on August 15, 2024

GlobeNewswire

4 months ago

BiomX to Host Second Quarter 2024 Financial Results Conference Call and Webcast on August 15, 2024

BiomX Inc. Announces NYSE American Acceptance of Plan to Regain Listing Compliance

GlobeNewswire

5 months ago

BiomX Inc. Announces NYSE American Acceptance of Plan to Regain Listing Compliance

BiomX Inc. Announces Stockholder Approval for Conversion of Outstanding Series X Convertible Preferred Stock to Common Stock

GlobeNewswire

5 months ago

BiomX Inc. Announces Stockholder Approval for Conversion of Outstanding Series X Convertible Preferred Stock to Common Stock

BiomX Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

GlobeNewswire

7 months ago

BiomX Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

BiomX to Present Phase 1b/2a Clinical Trial Data for BX004 at the 47th European Cystic Fibrosis Conference and at ASM Microbe 2024

GlobeNewswire

7 months ago

BiomX to Present Phase 1b/2a Clinical Trial Data for BX004 at the 47th European Cystic Fibrosis Conference and at ASM Microbe 2024

BiomX Reports First Quarter 2024 Financial Results and Provides Business and Program Updates

GlobeNewswire

7 months ago

BiomX Reports First Quarter 2024 Financial Results and Provides Business and Program Updates

BiomX to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 21, 2024

GlobeNewswire

7 months ago

BiomX to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 21, 2024

BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)

GlobeNewswire

8 months ago

BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)

BiomX Announces the Appointment of Susan Blum to its Board of Directors

GlobeNewswire

8 months ago

BiomX Announces the Appointment of Susan Blum to its Board of Directors

Here's Why BiomX (PHGE) Is a Great 'Buy the Bottom' Stock Now

Zacks

9 months ago

Here's Why BiomX (PHGE) Is a Great 'Buy the Bottom' Stock Now

BiomX Announces Compliance with NYSE Guidelines on Audit Opinion Disclosure

GlobeNewswire

9 months ago

BiomX Announces Compliance with NYSE Guidelines on Audit Opinion Disclosure

BiomX Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

GlobeNewswire

9 months ago

BiomX Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

BiomX to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast on April 3rd, 2024

GlobeNewswire

9 months ago

BiomX to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast on April 3rd, 2024

BiomX Announces Closing of the Acquisition of Adaptive Phage Therapeutics and Concurrent $50 Million Financing

GlobeNewswire

9 months ago

BiomX Announces Closing of the Acquisition of Adaptive Phage Therapeutics and Concurrent $50 Million Financing

BiomX Announces Entry into Merger Agreement with Adaptive Phage Therapeutics and Concurrent $50 Million Financing

GlobeNewswire

10 months ago

BiomX Announces Entry into Merger Agreement with Adaptive Phage Therapeutics and Concurrent $50 Million Financing

Investors in Sensus Healthcare (NASDAQ:SRTS) from a year ago are still down 60%, even after 24% gain this past week

Simply Wall St.

a year ago

Investors in Sensus Healthcare (NASDAQ:SRTS) from a year ago are still down 60%, even after 24% gain this past week

Airship AI Issues Stockholder Letter and Provides Corporate Update

GlobeNewswire

a year ago

Airship AI Issues Stockholder Letter and Provides Corporate Update

LiveOne (Nasdaq: LVO) Provides Update for Its $10M Stock Repurchase Program

GlobeNewswire

a year ago

LiveOne (Nasdaq: LVO) Provides Update for Its $10M Stock Repurchase Program

Montana Technologies Enters Joint Commercialization Agreement Term Sheet with Carrier Global to Provide Carbon-Reducing Cooling Technology for Key Global Markets

PR Newswire

a year ago

Montana Technologies Enters Joint Commercialization Agreement Term Sheet with Carrier Global to Provide Carbon-Reducing Cooling Technology for Key Global Markets

Vicinity Motor Corp. Announces VMC 1200 Distribution Agreement with Shift EV Trucks in West Toronto, Canada

ACCESSWIRE

a year ago

Vicinity Motor Corp. Announces VMC 1200 Distribution Agreement with Shift EV Trucks in West Toronto, Canada

Atara Biotherapeutics to Present Recent Progress and Key Upcoming Milestones at the 42nd Annual J.P. Morgan Healthcare Conference

Business Wire

a year ago

Atara Biotherapeutics to Present Recent Progress and Key Upcoming Milestones at the 42nd Annual J.P. Morgan Healthcare Conference

Zacks Small Cap Research

a year ago

PRTG: Bridging I-O: Working in Harmony with Checkpoints

SCYNEXIS to Present Preclinical Data on Second Generation Fungerp SCY-247 at the 11th Advances Against Aspergillosis and Mucormycosis Conference, January 25 – 27, in Milan, Italy

GlobeNewswire

a year ago

SCYNEXIS to Present Preclinical Data on Second Generation Fungerp SCY-247 at the 11th Advances Against Aspergillosis and Mucormycosis Conference, January 25 – 27, in Milan, Italy

Portage Biotech Reports Business and Strategic Update

GlobeNewswire

a year ago

Portage Biotech Reports Business and Strategic Update

ProPhase poised to ramp up growth at Pharmaloz and Nebula Genomics in 2024

GlobeNewswire

a year ago

ProPhase poised to ramp up growth at Pharmaloz and Nebula Genomics in 2024

BiomX Receives Orphan Drug Designation from the U.S. Food and Drug Administration for BX004 for the Treatment of Chronic Pulmonary Infection Caused by Pseudomonas aeruginosa in Patients with Cystic Fibrosis

GlobeNewswire

a year ago

BiomX Receives Orphan Drug Designation from the U.S. Food and Drug Administration for BX004 for the Treatment of Chronic Pulmonary Infection Caused by Pseudomonas aeruginosa in Patients with Cystic Fibrosis

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

The Zacks Analyst Blog Highlights Sunoco LP, CrossAmerica Partners, Liberty Energy, SLB and Nine Energy Service

Zacks

a year ago

The Zacks Analyst Blog Highlights Sunoco LP, CrossAmerica Partners, Liberty Energy, SLB and Nine Energy Service

BriaCell Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer Patients

GlobeNewswire

a year ago

BriaCell Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer Patients

These Stocks under $10 Are Poised To Explode

Insider Monkey

a year ago

These Stocks under $10 Are Poised To Explode

Achilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Prediction

GlobeNewswire

a year ago

Achilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Prediction

Optimistic Investors Push Koss Corporation (NASDAQ:KOSS) Shares Up 32% But Growth Is Lacking

Simply Wall St.

a year ago

Optimistic Investors Push Koss Corporation (NASDAQ:KOSS) Shares Up 32% But Growth Is Lacking

Returns On Capital Are Showing Encouraging Signs At Top Ships (NASDAQ:TOPS)

Simply Wall St.

a year ago

Returns On Capital Are Showing Encouraging Signs At Top Ships (NASDAQ:TOPS)

12 Best Micro-Cap Dividend Stocks To Buy Now

Insider Monkey

a year ago

12 Best Micro-Cap Dividend Stocks To Buy Now

When To Sell Growth Stocks: Why This Rule Worked Like Magic For This Small-Cap Leader

Investor's Business Daily

a year ago

When To Sell Growth Stocks: Why This Rule Worked Like Magic For This Small-Cap Leader

Collective Audience Appoints Technology Visionary, Investor, and Executive Leader, Peter Bordes, as Chief Executive Officer

GlobeNewswire

a year ago

Collective Audience Appoints Technology Visionary, Investor, and Executive Leader, Peter Bordes, as Chief Executive Officer

Dan Bongino Extends Contract With Westwood One, Recommits to Broadcast Radio

GlobeNewswire

a year ago

Dan Bongino Extends Contract With Westwood One, Recommits to Broadcast Radio

Investor Favorites: 7 Dividend Stocks with Strong Buy Ratings

InvestorPlace

a year ago

Investor Favorites: 7 Dividend Stocks with Strong Buy Ratings

Annovis Bio Appoints Andrew Walsh as Vice President Finance

GlobeNewswire

a year ago

Annovis Bio Appoints Andrew Walsh as Vice President Finance

BiomX to Host Virtual Key Opinion Leader (KOL) Event to Review the Positive Results from Part 2 of Phase 1b/2a Trial of BX004 in Cystic Fibrosis Patients with Chronic Pseudomonas aeruginosa Infections on December 4, 2023

GlobeNewswire

a year ago

BiomX to Host Virtual Key Opinion Leader (KOL) Event to Review the Positive Results from Part 2 of Phase 1b/2a Trial of BX004 in Cystic Fibrosis Patients with Chronic Pseudomonas aeruginosa Infections on December 4, 2023

Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q

GlobeNewswire

a year ago

Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q

BiomX Announces Positive Topline Results from Part 2 of the Phase 1b/2a Trial Evaluating BX004 for Treatment of Chronic Pulmonary Infections in Patients with Cystic Fibrosis

GlobeNewswire

a year ago

BiomX Announces Positive Topline Results from Part 2 of the Phase 1b/2a Trial Evaluating BX004 for Treatment of Chronic Pulmonary Infections in Patients with Cystic Fibrosis

Cineverse Inks Global Commercial YouTube Channel Agreement with Little Dot Studios

PR Newswire

a year ago

Cineverse Inks Global Commercial YouTube Channel Agreement with Little Dot Studios

Lucid Diagnostics Inc. (NASDAQ:LUCD) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Lucid Diagnostics Inc. (NASDAQ:LUCD) Q3 2023 Earnings Call Transcript

These Cathie Wood Stocks Are On Sale Now

Insider Monkey

a year ago

These Cathie Wood Stocks Are On Sale Now

CXApp Inc. (NASDAQ:CXAI) Announces Q3 2023 Financial Results: Record Growth & Industry Momentum for CXAI Platform

ACCESSWIRE

a year ago

CXApp Inc. (NASDAQ:CXAI) Announces Q3 2023 Financial Results: Record Growth & Industry Momentum for CXAI Platform

Creative Realities illuminates Airport Shopping with Engaging LED Experiences

GlobeNewswire

a year ago

Creative Realities illuminates Airport Shopping with Engaging LED Experiences

BiomX Reports Third Quarter 2023 Financial Results and Provides Business Update

GlobeNewswire

a year ago

BiomX Reports Third Quarter 2023 Financial Results and Provides Business Update

KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire

a year ago

KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Heritage Global Inc. (NASDAQ:HGBL) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Heritage Global Inc. (NASDAQ:HGBL) Q3 2023 Earnings Call Transcript

Associated Press Finance

a year ago

VTv Therapeutics: Q3 Earnings Snapshot

vTv Therapeutics Announces 2023 Third Quarter Financial Results and Provides Corporate Update

GlobeNewswire

a year ago

vTv Therapeutics Announces 2023 Third Quarter Financial Results and Provides Corporate Update

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

PR Newswire

a year ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Myomo, Inc. (AMEX:MYO) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Myomo, Inc. (AMEX:MYO) Q3 2023 Earnings Call Transcript

Rapid Micro Biosystems to Participate in Upcoming Investor Conferences

GlobeNewswire

a year ago

Rapid Micro Biosystems to Participate in Upcoming Investor Conferences

Nkarta to Participate at Upcoming Investor Conferences

GlobeNewswire

a year ago

Nkarta to Participate at Upcoming Investor Conferences

Business Wire

a year ago

SmartRent Reports Third Quarter 2023 Results

Share on Social Networks: